Beyond Body Mass Index: Bringing Body Composition into Oncology Practice

超越体重指数:将身体成分纳入肿瘤学实践

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT This Career Development Award will support Elizabeth Feliciano, ScD, in her transition to independence as a translational researcher utilizing electronic data to improve cancer care. Her long-term goals are to elucidate how body composition influences cancer outcomes; develop electronic tools that use routinely collected data to improve prognostication and guide clinical interventions; and collaborate to use these electronic tools in interventions that improve cancer outcomes. Sarcopenia (low skeletal muscle mass) and sarcopenic obesity (sarcopenia with excess adiposity) are common in cancer patients, typically occult, and associated with surgical complications, treatment toxicity, poor quality of life, and reduced survival across a variety of cancer types. Despite being strongly prognostic and modifiable, body composition data is under-utilized in clinical decision-making. To address this, Dr. Feliciano will develop cost-effective, clinic-friendly methods to identify patients with sarcopenia. Next, she will develop a tool that communicates body composition information to a cancer care team. Using rich electronic medical record and imaging data from a cohort of nearly 6,000 non-metastatic colorectal and breast cancer patients, she will: validate software to automatically assess body composition from clinically-acquired imaging (Aim 1); develop a predictive model to identify sarcopenia based on electronic medical data, for use in cancer patients who do not undergo imaging (Aim 2); and integrate body composition information into established risk prediction models for colorectal cancer used in clinical practice and present this information in an understandable and actionable format to clinicians (Aim 3). Dr. Feliciano is well suited to perform this research based on her experience in body composition assessment and cancer epidemiology, an exceptional mentoring team who will ensure scientific rigor and clinical relevance, and the unique setting within an integrated healthcare system with a comprehensive electronic medical record and an ethnically diverse patient population of 4.1-million members. Her institution, Kaiser Permanente Northern California, provides an ideal training ground for her to gain needed skills through coursework, conferences, seminars, and experiential learning in the following domains: advanced analytic methods (predictive modeling, biomedical image analysis, and data visualization); cancer biology and clinical cancer care; and core competencies of an independent investigator (grant-writing, responsible conduct of research, and clinical translation of research).Through the proposed research and training, she will acquire the preliminary data, knowledge, and clinical and scientific partnerships she needs to develop a competitive R01 proposal and to establish a successful research program focused on optimizing use of electronic data to improve cancer care.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Marjorie Cespedes Feliciano其他文献

Elizabeth Marjorie Cespedes Feliciano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Marjorie Cespedes Feliciano', 18)}}的其他基金

Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample
了解肿瘤微环境中肥胖和脂肪因子相关 RNA 表达对种族和民族多样化样本中乳腺癌结果的作用
  • 批准号:
    10602753
  • 财政年份:
    2022
  • 资助金额:
    $ 17.84万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10029647
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10198876
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
  • 批准号:
    10242206
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
  • 批准号:
    10337029
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
  • 批准号:
    10407652
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10425385
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
  • 批准号:
    10579981
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
  • 批准号:
    10652340
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors - Disparities Supplement
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物 - Disparities Supplement
  • 批准号:
    10712034
  • 财政年份:
    2020
  • 资助金额:
    $ 17.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了